About
Peter Colabuono is a Managing Director at Decheng Capital, where he has worked since October 2016, contributing finance, investment, transaction, operational, and drug development experience. Before Decheng, he held operational roles and worked as an Associate at Frazier Healthcare Ventures, where he led the investment and formation of Silvergate Pharmaceuticals, and earlier worked in the healthcare investment banking groups at Morgan Stanley and Cowen. He holds a B.A. in Molecular Biology and Biochemistry from Dartmouth College and is named as an inventor and author on patents and journal articles.
Invests in
Biotech
Experience
- Decheng CapitalManaging Directorcurrent2016 — presentMenlo Park, CA
- Ironwood PharmaceuticalsSenior Director, Business Development2015 — 2016Cambridge, MA
- Aquilo PartnersVice President2014 — 2015Cambridge, MA
- Silvergate PharmaceuticalsVice President of Managed Care & Corporate Development2011 — 2014
- Frazier Healthcare VenturesAssociate2008 — 2011
- Morgan StanleyAnalyst2006 — 2007
- Cowen & CompanyAnalyst2005 — 2006
Education
- Dartmouth CollegeBachelor of Arts (B.A.), Molecular Biology & Biochemistry2000 — 2004
Skills & more
+8 more
Start-upsCorporate FinanceCompetitive AnalysisBusiness DevelopmentEntrepreneurshipEmerging MarketsMedical DevicesM&A experienceFrom Peter's professional profile.
Same school
Also attended Dartmouth College310
+ 304 more
Shared employers
Also worked at Ironwood Pharmaceuticals2
Also worked at Aquilo Partners1
Also worked at Morgan Stanley843
+ 837 more
Investments
Led
Silvergate Pharmaceuticals
Board seats
AADi BioscienceAriagenCheckmate PharmaceuticalsConjugateBioFirefly BiologicsSolve TherapeuticsVelos Biopharma
Per the firm's website.
